These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 15347236

  • 1. [Plasma lipoprotein (a) values in familial defective ligand apo B 100 in a South European population].
    Ejarque I, Leal JT, Ascaso JF, Chaves FJ, Milian E, Priego MA, Carmena R.
    An Med Interna; 2004 Jul; 21(7):322-5. PubMed ID: 15347236
    [Abstract] [Full Text] [Related]

  • 2. [Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population].
    Ejarque I, Real JT, Chaves FJ, Blesa S, González V, Milian E, Ascaso JF, Priego MA, Carmena R.
    Med Clin (Barc); 2004 Oct 09; 123(12):456-9. PubMed ID: 15498441
    [Abstract] [Full Text] [Related]

  • 3. Sib-pair analysis detects elevated Lp(a) levels and large variation of Lp(a) concentration in subjects with familial defective ApoB.
    van der Hoek YY, Lingenhel A, Kraft HG, Defesche JC, Kastelein JJ, Utermann G.
    J Clin Invest; 1997 May 01; 99(9):2269-73. PubMed ID: 9151801
    [Abstract] [Full Text] [Related]

  • 4. [Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].
    Ejarque I, Civer M, Francisco Ascaso J, Knecht E, Eugenia Armengod M, Carmen R, Tomás Real J, Francisco Chaves J, Javier Martín De Llano J.
    Med Clin (Barc); 2001 Feb 03; 116(4):138-41. PubMed ID: 11222161
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein(a) in subjects with familial defective apolipoprotein B100.
    Perombelon YF, Gallagher JJ, Myant NB, Soutar AK, Knight BL.
    Atherosclerosis; 1992 Feb 03; 92(2-3):203-12. PubMed ID: 1385954
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.
    Hansen PS, Meinertz H, Jensen HK, Fruergaard P, Launbjerg J, Klausen IC, Lemming L, Gerdes U, Gregersen N, Faergeman O.
    Arterioscler Thromb; 1994 Feb 03; 14(2):207-13. PubMed ID: 8305410
    [Abstract] [Full Text] [Related]

  • 7. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT, Chaves FJ, Ejarque I, García-García AB, Valldecabres C, Ascaso JF, Armengod ME, Carmena R.
    Eur J Hum Genet; 2003 Dec 03; 11(12):959-65. PubMed ID: 14508510
    [Abstract] [Full Text] [Related]

  • 8. Distribution of serum apolipoproteins A-I and B and lipoprotein(a) in European elderly. The SENECA study.
    Contois JH, Wu AH, Li Z, Feroze AH, Grunenberger F, Haller J, deGroot L, Lammi-Keefe CJ.
    Clin Chim Acta; 2000 May 03; 295(1-2):1-12. PubMed ID: 10767390
    [Abstract] [Full Text] [Related]

  • 9. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect.
    Carmena R, Lussier-Cacan S, Roy M, Minnich A, Lingenhel A, Kronenberg F, Davignon J.
    Arterioscler Thromb Vasc Biol; 1996 Jan 03; 16(1):129-36. PubMed ID: 8548413
    [Abstract] [Full Text] [Related]

  • 10. Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.
    Pimstone SN, Defesche JC, Clee SM, Bakker HD, Hayden MR, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 1997 May 03; 17(5):826-33. PubMed ID: 9157944
    [Abstract] [Full Text] [Related]

  • 11. Familial ligand-defective apolipoprotein B-100: detection, biochemical features and haplotype analysis of the R3531C mutation in the UK.
    Wenham PR, Henderson BG, Penney MD, Ashby JP, Rae PW, Walker SW.
    Atherosclerosis; 1997 Mar 21; 129(2):185-92. PubMed ID: 9105560
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100.
    Raungaard B, Heath F, Hansen PS, Brorholt-Petersen JU, Jensen HK, Faergeman O.
    Clin Chem; 2000 Feb 21; 46(2):224-33. PubMed ID: 10657378
    [Abstract] [Full Text] [Related]

  • 13. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov 21; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 14. Familial defective apolipoprotein B-100.
    Hansen PS.
    Dan Med Bull; 1998 Sep 21; 45(4):370-82. PubMed ID: 9777289
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.
    de Bruin TW, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ, Erkelens DW.
    J Clin Endocrinol Metab; 1993 Jan 21; 76(1):121-6. PubMed ID: 8421075
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J, Dufour R, Roy M, Bétard C, Ma Y, Ouellette S, Boulet L, Lussier-Cacan S.
    Eur J Epidemiol; 1992 May 21; 8 Suppl 1():10-7. PubMed ID: 1505645
    [Abstract] [Full Text] [Related]

  • 17. The apolipoprotein B R3500Q gene mutation in Spanish subjects with a clinical diagnosis of familial hypercholesterolemia.
    Castillo S, Tejedor D, Mozas P, Reyes G, Civeira F, Alonso R, Ros E, Pocoví M, Mata P.
    Atherosclerosis; 2002 Nov 21; 165(1):127-35. PubMed ID: 12208478
    [Abstract] [Full Text] [Related]

  • 18. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB.
    N Engl J Med; 2005 Jul 07; 353(1):46-57. PubMed ID: 16000355
    [Abstract] [Full Text] [Related]

  • 19. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs.
    Schaefer JR, Scharnagl H, Baumstark MW, Schweer H, Zech LA, Seyberth H, Winkler K, Steinmetz A, März W.
    Arterioscler Thromb Vasc Biol; 1997 Feb 07; 17(2):348-53. PubMed ID: 9081691
    [Abstract] [Full Text] [Related]

  • 20. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN, Stocks J, Cooke CJ, Molhuizen HO, Marcovina S, Crook D, Kastelein JP, Miller NE.
    Atherosclerosis; 2003 Sep 07; 170(1):105-13. PubMed ID: 12957688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.